Abstract
Objective : To see the additional benefit of combined frequent nebulization with salbutamol and ipratropium bromide in acute attack of asthma with moderate severity.Methods : Fifty asthmatic children in the age range of 6–14 years were divided into two equal groups. Group I children were nebulized with three doses of Salbutamol alone (0.03 ml/kg/dose) and Group II children were given combined nebulization of Salbutamol (dose as in group I) and Ipratropium bromide (250 Μgm/dose for three doses) at 20 minutes interval. Children were observed at 15, 30, 60,120,180 and 240 minutes interval.Results : A significant improvement in % of PEFR starting at 30 minutes and lasting the entire study period of 4 hours was noted in both the groups. However on analysis of varience the results were better in group II.Conclusion : Frequent combined nebulization with Salbutamol and Ipratropium bromide is beneficial in acute asthma of moderate severity.
Similar content being viewed by others
References
Schuh S, Parkin P, Rajan Aet al. High-versus low dose, frequently administered, nebulized albuterol in children with severe, acute asthma.Pediatrics 1989; 83: 513–518.
Guidelines for the diagnosis and management of asthma: National Heart, Lung and Blood Institute, National Asthma Education Program. Expert Panel Report.J Allergy Clin Immunol 1991; 88: 425–534.
Becker AB, Nelson NA, Sumons FER. Inhaled Salbutamol (albuterol) Vs injected epinephrine in the treatment of acute asthma in children.J Pediatr 1983; 102: 465–469.
Fischl MA, Pitchenik A, Gardner LB. An index predicting relapse and need for hospitalization in patients with acute bronchial asthma.N Engl J Med 1981; 305: 783–789.
Fanta CH, Rossing TH, McFadden ER Jr. Emergency room treatment of asthma. Relationship among therapeutic combinations, severity of obstruction and time course of response.Am J Med 1982; 72: 416–422.
Gandevia B. Historical view of the use of parasympatholytic agents in the treatment of respiratory disorders.Postgrad Med J 1975; 51(Suppl7): 13–20.
Gross NJ, Skorodin MS. State of the art. Anticholinergic antimuscarinic bronchodilators.Am Rev Respir Dis 1984; 129: 856–870.
Ullah MI, Newman GB, Saunders KB. Influence of age on response to ipratropium and salbutamol in asthma.Thorax 1981; 36: 523–529.
Buhr W, Jones Jorres R, Berdel D, Landser FJ. Correspondence between forced oscillation andbody plethysmography during bronchoprovocation with carbachol in children.Pediatr Pulmonol 1990; 8: 280–288.
Warner JO, Naspitz CK. Third internation pediatric consensus statement on the management of childhood asthma.Pediatr Pulmonol 1998; 25: 1–17.
Plotnick L, Ducharme FM. Efficacy and safety of combined inhaled anticholinergics and beta-2 agonists in the initial management of acute pediatric asthma. In Cates C, Ducharme FM, Gibson P, Jones P, Rowe B, Wolf F, eds.Airways Module of the Cochrane Betabase of Systematic Reviews. The Cochrane Collaboration, Issue 2, Oxford’. Update Software: 1997.
Rebuck AS, Chapman KR, Braude AC. Anticholinergic therapy of asthma.Chest 1982; 82 (1) (Suppl): 55S-57S.
Rebuck AS, Chapman KR, Abbound Ret al. Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency room.Am J Med 1987; 82: 59–64.
O’Driscole BF, Taylor RJ, Horsley M, Chambers DK, Bernstein A. Nebulized Salbutamol with and without ipratropium bromide in acute airflow obstruction.Lancet 1989; 1: 1418–1420.
Higgins RM, Stradling RJ, Lane DM. Should ipratropium bromide be added to beta agonists in treatment of severe acute asthma?Chest 1988; 94: 718–722.
Warner JO, Naspitz CK. Third international pediatric consensus statement on the management of childhood asthma.Pediatr Pulmnol 1998; 25: 1–17.
British Thoracic Societyet al. The British guidelines on asthma management: 1995 review and position statement.Thorax 1997; 52: S1-S22.
Canadian Asthma Consensus Conference. Summary of recommendations.Can Respir J 1996; 3: 89–100.
International Pediatric Asthma Consensus group. Asthma: A follow up statement.Arch Dis Child 1992; 67: 240–248.
Parmar VR, Kumar L, Malik SK. Normal values of peak expiratory flow rate in healthy North Indian Children 6–16 years of age.Indian Pediatr 1977; 14: 591–4.
Sly RM. Allergic Disorders. In Nelson WE, Beherman RE, Kliegman RM, Arvin AM, eds.Nelson Text Book of Pediatrics, 15th edn. Philadelphia WB Saunders Co., 1996; 610–656.
Warner JO, Gotz M, Landan LIet al. Management of asthma: A censensus Statement.Arch Dis Child 1989; 64: 1065–1079.
Schuh S, Johnson DW, Callahan S, Canny G, Levison H. Efficacy of frequent nebulized ipratropium bromide added to frequent high dose albuterol therapy in severe childhood asthma.J Pediatr 1995; 126: 639–645.
Reisman J, Galdes-Sebalt M, Kazim F, Canny G, Levison H. Frequent administration by inhalation of Salbutamol and ipratropium bromide in the initial management of severe acute asthma in children.J Allergy Clin Immunol 1988; 81(1): 16–20.
Lenney W, Evans NAP. Nebulized salbutamol and ipratropium bromide in asthmatic children.Br J Dis Chest 1986; 80: 59–65.
Ruffin RE, Fitzgerald JD, Revuck AS. A comparison of the bronchodilator activity of Sch 1000 and Salbutamol.J Allerg Clin Immunol 1977; 59: 136–141.
Lightbody IM, Ingram CG, Legge JS, Johnston RN. Ipratropium bromide, Salbutamol and prednisolone in bronchial asthma and chronic bronchitis.Br J Dis Chest 1978; 72: 181–186.
Ducharme FM, Davis GM. Randomized controlled trial of ipratropium bromide and frequent low doses of Salbutamol in the management of mild and moderate acute pediatric asthma.J Pediatr 1998; 133: 479–485.
Guill MF, Maloney MJ, DuRant RH. Comparison of inhaled metaproterenol, inhaled atropine sulphate, and their combination in the treatment of children with acute asthma.Ann Allerg 1987; 59: 367–71.
Beck R, Robertson C, Galdes-Sebaldt M, Levison H. Combined salbutamol and ipratropium bromide by inhalation in the treatment of severe acute asthma.J Pediatr 1985; 107(4): 605–608.
Storms WW, Dopico GA, Reed CE. Aerosol sch 1000: an anticholinergic brochodilator.Am Rev Respir Dis 1975; 111: 419.
De Troyer A, Yernault JC, Rodenstein D. Effect of vagal blockade on lung mechanics in normal man.J Appl Physiol 1979; 46: 217–226.
Ingram RH, Wellman JJ, McFadden ER, Mead J. Relative contributions of large andsmall airways to flow limitation in normal subjects before and after atropineand isoproterenol.J Clin Invest 1977; 59: 696–703.
Hensley MJ, O’Cain CF, McFadden ER, Ingram RH. Distribution of bronchodilatation in normal subjects: beta agonist versus atropine.J Appl Physiol 1978; 45: 778–782.
Cookson DU, Reed CE. A comparison of the effects of isoproterenol in the normal and asthmatic subject.Am Rev Respir Dis 1963; 88: 636–643.
Chervinsky P. Double blind study of ipratropium bromide, a new anticholinergic bronchodilator.J Allergy Clin Immunol 1977; 59(1): 22–30.
Clark PS, Jarrett RG, Hall GJL. The protective effect of ipratropium bromide aerosol against bronchospasm induced by hyperventilation and the inhalation of allergen, methacholine and histamine.Ann Allergy 1982; 48: 180–182.
Ward MJ, MacFarlane JT, Davies D. Treatment of acute severe asthma with intravenous aminophylline and nebulized ipratropium bromide after Salbutamol (abstr).Thorax 1982; 37: 785.
Summers QA, Tarala RA. Neubilized ipratropium in the treatment of acute asthma.Chest 1990; 97: 430–434.
Milner AD. Bronchodilator drugs in childhood asthma.Arch Dis Child 1981; 56: 84–85.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sharma, A., Madaan, A. Nebulized salbutamol vs salbutamol and ipratropium combination in asthma. Indian J Pediatr 71, 121–124 (2004). https://doi.org/10.1007/BF02723090
Issue Date:
DOI: https://doi.org/10.1007/BF02723090